Targeted News Service

TCC Signs 50K-SF HQ/Lab Lease With COUR Pharmaceuticals at Evanston Labs on Chicago's North Shore
November 23, 2024

DALLAS, Texas, Nov. 23 -- Trammell Crow Co., a developer and investor in commercial real estate, issued the following news release:

* * *

The company plans to occupy the space in Q4 2025

* * *

Trammell Crow Company (TCC), a global real estate developer, has signed a lease with COUR Pharmaceuticals at Evanston Labs in Evanston, Illinois. The company is relocating its headquarters, R&D lab, and pilot manufacturing plant to the recently delive . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form